DEVICE AND METHOD FOR NEUROSTIMULATION
20200316370 ยท 2020-10-08
Inventors
- Yael HANEIN (Cesarea, IL)
- Niyazi Serdar SARICIFTCI (Linz, AT)
- Eric Daniel GLOWACKI (Warszawa, PL)
- David RAND (Nes-Ziona, IL)
- Gur LUBIN (Tel Aviv-Yafo, IL)
- Marie JAKESOVA (Brno-Ivanovice, CZ)
Cpc classification
H10K85/761
ELECTRICITY
Y02P70/50
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
H10K30/20
ELECTRICITY
A61N1/3605
HUMAN NECESSITIES
Y02E10/549
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
H10K85/621
ELECTRICITY
International classification
Abstract
An efficient nanoscale semiconducting optoelectronic system, containing a P/N acceptor donor organic hetrojunction which is optimized for neuronal stimulationan organic electrolytic photocapacitor. The devices comprise a thin (80 nm) trilayer of metal and p-n semiconducting organic nanocrystals. When illuminated in physiological solution, these metal-semiconductor devices charge up, transducing light pulses into localized displacement currents that are strong enough to electrically stimulate neurons with safe light intensities.
Claims
1. A device for neurostimulating a tissue in a physiological medium, the device comprising a multilayer comprising at least one metal or a conductive material layer and p-n/n-p structure layered thereon, the p-n/n-p structure comprising semiconducting organic nanocrystals.
2. The device according to claim 1, wherein the p-n/n-p structure is in continuous contact with the at least one metal or the conductive material layer, wherein the at least one metal or the conductive material layer is configured to be in electrical contact with a physiological medium in which the device operates, the p-n/n-p structure comprising a combination of two or more organic semiconductor pigments, at least one being selected amongst electron donor materials (a p-type material) and at least one other selected amongst electron accepting materials (an n-type material).
3. The device according to claim 2, the device comprising a metal layer or a conductive material layer, a layer of at least one light-absorbing (electron donor) material that is in continuous contact with the metal or the conductive material layer and a layer of at least one electron acceptor material that is in continuous contact with the layer of the at least one light-absorbing material.
4. The device according to claim 2, the device comprising a metal layer or a conductive material layer, a layer of at least one electron acceptor material that is in continuous contact with the metal or the conductive material layer and a layer of at least one light-absorbing (electron donor) material that is in continuous contact with the layer of the at least one electron acceptor material.
5. The device according to claim 2, the device comprising a substrate, at least one metal layer or a conductive material layer formed onto one or more regions of the substrate, and a p-n/n-p structure formed on at least one of the metal layer or metal regions.
6. The device according to claim 2, the device comprising a metal layer or a conductive material layer, a layer consisting of at least one p-type organic pigment material or a layer consisting of at least one n-type organic pigment material that is stacked onto at least a region of said metal layer.
7. The device according to claim 2, being a photocapacitor.
8. A photocapacitor device for responding to a light of a selected wavelength, said device comprising a first region comprising at least one metal or conductive material; and a second region composed of a p-n/n-p structure, wherein the first region is formed on a substrate in the form of a layer or a film onto which the second region, being in the form of a film structure or a multi-layered structure, is formed.
9. The device according to claim 1, wherein the p-n/n-p structure is a p-n structure or an n-p structure.
10. (canceled)
11. The device according to claim 2, wherein the p-type material is selected amongst organic semiconductor pigments, optionally polymeric.
12. The device according to claim 11, wherein the p-type material is selected from metal-containing or metal-free phthalocyanine (H.sub.2Pc), 2,3-naphthalocyanine, benz[b]anthracene, 5,5-Bis(2,2-dicyanovinyl)-2,2:5,2: 5,2:5,2-quinquethiophene, bis(ethylenedithio) tetrathiafulvalene, 2-[(7-{4-[N,N-bis(4-methylphenyl)amino]phenyl}-2,1,3-benzothiadiazol-4-yl)methylene]propanedinitrile, 6,13-bis((triethylsilyl)ethynyl) pentacene, Coronene, dibenzotetrathiafulvalene, 5,5-Di(4-biphenylyl)-2,2-bithiophene, 3,3-Didodecyl-2,2:5,2:5,2-quaterthiophene, 5,5-Dihexyl-2,2-bithiophene, 3,3-dihexyl-2,2:5,2:5,2-quaterthiophene, 5,5-Dihexyl-2,2:5,2:5,2:5, 2:5, 2-sexithiophene, dinaphtho[2,3-b:2,3-f]thieno[3,2-b]thiophene, 2-[7-(4-diphenylaminophenyl)-2,1,3-benzothiadiazol-4-yl]methylenepropanedinitrile, 2,6-diphenylbenzo[1,2-b:4,5-b]dithiophene, 2,7-diphenyl[1]benzothieno[3,2-b][1]benzothiophene, 6,13-diphenylpentacene, 2-{[7-(5-N,N-ditolylaminothiophen-2-yl)-2,1,3-benzothiadiazol-4-yl]methylene}malononitrile, 2,6-ditolylbenzo[1,2-b:4,5-b]dithiophene, Merocyanine dye, 13,6-N-sulfinylacetamidopentacene, tris[4-(5-dicyanomethylidenemethyl-2-thienyl)phenyl]amine, Rubrene, -sexithiophene, tetrathiafulvalene, epindolidione, quinacridone, indanthrene, flavanthrone and violanthrone.
13. The device according to claim 12, wherein the p-type material is a metal containing or metal free phthalocyanine (H.sub.2Pc).
14. (canceled)
15. The device according to claim 2, wherein the n-type material is selected amongst organic semiconductor pigments, optionally polymeric.
16. The device according to claim 15, wherein the n-type material is selected from N,N-dimethyl perylenetetracarboxylic diimide (PTCDI), N,N-bis(2,5-di-tert-butylphenyl)-3,4,9,10-perylenedicarboximide, 1,3,6,8(2H,7H)-tetraone, 2,7-dicyclohexylbenzo[lmn] [3,8]phenanthroline, 1,3,8,10(2H,9H)-tetraone, 2,9-bis(2-phenylethyl)anthra[2,1,9-def:6,5,10-def]diisoquinoline, fullerene, 5,10,15,20-Tetrakis(pentafluorophenyl)-21H,23H-porphine, 7,7,8,8-tetracyanoquinodimethane, 2,3,5,6-tetrafluoro-7,7,8,8-tetracyanoquinodimethane, 1,2,3,4,5,6,7,8-octafluoro-9,10-bis[2-(2,4,6-trimethylphenyl)ethynyl]anthracene, 1,2,3,4,5,6,7,8-octafluoro-9,10-bis[4-(trifluoromethyl)phenyl]anthracene, 1,4,5,8-naphthalenetetracarboxylic dianhydride, Indeno[1,2-b]fluorene-6,12-dione, 2,9-dipropylanthra[2,1,9-def:6,5,10-def]diisoquinoline-1,3,8,10(2H,9H)tetrone, N,N-dipentyl-3,4,9,10-perylene dicarboximide, 1,3-dimethyl-2-phenyl-2,3-dihydro-1H-benzoimidazole, 4-(2,3-dihydro-1,3-dimethyl-1H-benzimidazol-2-yl)-N,N-dimethylbenzenamine, N,N-dimethyl-3,4,9,10-perylenedicarboximide, 4-(1,3-dimethyl-2,3-dihydro-1H-benzoimidazol-2-yl)-N,N-diphenylaniline, 2,9-dihexylanthra[2,1,9-def:6,5,10-def]diisoquinoline-1,3,8,10 (2H,9H)tetrone, 2,7-dihexylbenzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetrone, 2,9-diheptylanthra[2,1,9-def:6,5,10-def]diisoquinoline-1,3,8,10(2H,9H) tetrone, 1,7-dibromo-3,4,9,10-tetracarboxylic acid dianhydride, 6,12-bis(2,4,6-trimethylphenyl) indeno[1,2-b]fluorine, 1,2,3,4,8,9,10,11,15,16,17,18,22,23,24,25-hexadecafluoro-29H,31H-phthalocyanine, 2,2-bis[4-(trifluoromethyl)phenyl]-5,5-bithiazole, 5,5-bis(tridecafluorohexyl)-2,2:5,2:5,2-quaterthiophene, N,N-bis(3-pentyl)perylene-3,4,9,10-bis(dicarboximide), 6,12-bis(2,3,4,5,6-pentafluorophenyl)indeno[1,2-b] fluorine, 2,9-bis[(4-methoxyphenyl)methyl]anthra[2,1,9-def:6,5,10-def]diisoquinoline 1,3,8,10(2H,9H)tetrone, bisbenzimidazo[2,1-a:2,1-a]anthra[2,1,9-def:6,5,10-def]diisoquinoline-10,21-dione, indigo, 6,6-dibromoindigo (tyrian purple), isoindigo, indanthrone, diindeno[1,2,3-cd:1,d,3-jk]pyrene, diindeno[1,2,3-de,1,2,3-kl]anthracene and dinaphth[1,2-a: 1,2-h]anthracene.
17. The device according to claim 16, wherein the n-type material is N,N-dimethyl perylenetetracarboxylic diimide (PTCDI).
18.-30. (canceled)
31. The device according to claim 1, the device being photoresponsive at a wavelength between 400 and 2,000 nm.
32. (canceled)
33. The device according to claim 1 being wire free.
34.-36. (canceled)
37. A method for stimulating an excitable tissue or cell, the method comprising placing or positioning into, onto or in the vicinity of a target excitable tissue or cell at least one photoresponse device according to claim 1; and focusing light with a wavelength between 400-2,000 nanometers onto the device, to thereby cause a photoresponse effect (electrical pulse), and stimulation of the excitable tissue or cells.
38. A method of generating an electrical pulse at the vicinity of a biological tissue or cell, the method comprising positioning into, onto or in the vicinity of a target excitable tissue or cell at least one photoresponse device according to claim 1; and focusing light with a wavelength between 400-2,000 nanometers onto the device, to thereby generate an electrical pulse.
39. A device according to claim 1 configured as a retinal implant.
40.-41. (canceled)
42. A photoresponse device comprising a Cr/Au bilayer and a p-n structure being in continuous contact with the Cr/Au layer, the p-n structure comprising phthalocyanine (H.sub.2Pc) and N,N-dimethyl perylenetetracarboxylic diimide (PTCDI).
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0062] In order to better understand the subject matter that is disclosed herein and to exemplify how it may be carried out in practice, embodiments will now be described, by way of non-limiting example only, with reference to the accompanying drawings, in which:
[0063]
[0064]
[0065]
[0066]
[0067]
[0068]
[0069]
[0070]
[0071]
[0072]
DETAILED DESCRIPTION OF EMBODIMENTS
[0073] Materials
[0074] Phthalocyanine H.sub.2Pc (Alfa Aesar), ZnPc (BASF) and CuPc (BASF) were each purified by three-fold temperature gradient sublimation in a vacuum of <110.sup.3 torr. PTCDI, N,N-Dimethyl-3,4,9,10-perylenetetracarboxylic Diimide (BASF), was likewise purified thrice by sublimation.
[0075] Device Fabrication
[0076] Photocapacitor devices were fabricated using physical vapour deposition processes either on clean microscope slide glass or on commercial multielectrode arrays (Multichannel Systems GmbH), with both metal and organic regions defined by stainless steel shadow masks. Both glass and MEA substrates, after solvent cleaning, were treated with UV-generated ozone and a layer of chromium (2 nm) followed by gold (18 nm) was evaporated at a base pressure of <110.sup.6 mbar at a rate of 0.2 /s and 3-5 /s, respectively. It is known that following these fabrication procedures gives primarily Cr.sub.2O.sub.3 rather than metallic Cr. Following evaporation, the samples were exposed to UV-generated ozone for 15 minutes and then placed into a chamber held at 75 C. containing vapour of n-octyltriethoxysilane (OTS) for 2 hr. Following OTS treatment the substrates were rinsed with acetone and water and placed in boiling acetone for 15 minutes to remove multilayers and excess silanisation physioadsorbed on the Cr/Au or TiN electrodes (the latter in the case of MEA). The OTS layer was found to improve the adhesion of the organic semiconductor layer and prevent delamination, and produced reliably higher photovoltage than bare Cr/Au. Following rinsing with isopropanol and water and drying under a nitrogen stream, the samples were placed with appropriate shadow masking in an organic materials evaporator. The pigment layers were evaporated at a rate of 0.5 /s for the p-type layer and 5-6 /s for the n-type at a base pressure of <110.sup.6 mbar, to give a total thickness of 60 nm consisting of 30 nm of p- and n-type.
[0077] Photo-Response Characterization
[0078] The illumination unit consisted of a light-emitting diode (LED) with a peak wavelength of 660 nm (Thorlabs) mounted on an Olympus upright microscope (BX51WI) using a 4 or water immersion objectives of 10, 20, and 40, resulting in illumination intensities within the range of 0.6-1725 mW/cm.sup.2. The measurement unit consisted of a current amplifier (model 1212; DL Instruments) or voltage amplifier (model ELC-03XS, npi electronic GmbH). A photogenerated voltage was measured between the underlying metal electrode and a reference electrode (either Au or Ag/AgCl) in phosphate buffered saline (PBS) or modified Tyrode's solution (5 mM KCl, 25 mM NaHCO.sub.3, 10 mM glucose, 1.2 mM MgSO.sub.4, 1.2 mM HEPES, 0.5 mM glutamine, 2.5 mM CaCl.sub.2). Voltage transients were recorded using a micropipette electrode filled with 3M KCl, mounted on a computer motorized micromanipulator (model PatchStar, Scientifica) vs. Ag/AgCl reference electrode in the electrolyte.
[0079] A Xenon-Discharge Lamp and Czerny-Turner Monochromator were used as light source to acquire the photocurrent spectra. The photocurrents were amplified using a Lock-in amplifier and chopper operated at 29 Hz. The current rms values were acquired as a function of wavelength and normalized for the light intensity as measured with a pyroelectric detector. Impedance spectra were acquired in 0.1 M KCl with a Metro-Ohm PGSTAT 204 at OCP conditions.
[0080] Electrostatic Modeling
[0081] Electric potential distribution of the device immersed in electrolyte was modeled using the Robin Hood Solver software package for complex 3D electrostatic problems using the Robin Hood calculation method. Charged photocapacitor devices were modeled as two concentric metal plateslarger bottom gold electrode fixed at 0V potential, and the smaller top electrode which represented an equipotential surface at the top of the p-n junction, and which could be set at arbitrary potentials depending on the modeled electrode. The electrodes in the model were separated by a thin dielectric layer with relative permittivity of 3, characteristic to the organic semiconductors used here. The dielectric layer in the model represented the p-n junction region of the device. The space surrounding the device was modeled as a dielectric with relative permittivity of 80.1, representing a water-based electrolyte. All the dimensions in the model were true to the experimentally measured devices.
[0082] Neural Culture
[0083] All mice were treated in accordance with the principles and procedures of the Israel National Institute of Health and the United States National Institutes of Health (NIH) Guidelines for the Care and Use of Laboratory Animals. Protocols were approved by the Institutional Animal Care and Use Committee of the Tel Aviv University. Dissociated cortical cultures were prepared as follows: the entire cortices of SV129-mice, post-natal 0-1, were removed. Cortical tissue was digested with 0.065% trypsin (Biological Industries) in PBS for 15 min, followed by mechanical dissociation by trituration. Cells were re-suspended in a modified essential medium (MEM) without phenol red and glutamine, 5% horse serum, 50 mM glutamine, 0.02 mM glucose, 0.5% Pen-Strep, 2% B-27, and 0.75% glutamax (Gibco) and plated on either poly-D-lysine (PDL, Sigma) covered petri dish (control) or on type I samples (experiment) with a cell density of 3000 cells/mm.sup.2 (70010.sup.3 cells per dish). Cultures were maintained at 37 C. with 5% CO.sub.2. Growth medium was partially replaced every 3-4 days. At 4 DIV, cultures were infected with AAV-CAG-GCaMP6s viral vector (prepared by the Tel Aviv University vector core facility).
[0084] Optical Recording Via Calcium Imaging
[0085] Calcium imaging recordings were performed on 14 DIV in buffered mice artificial cerebrospinal solution (mice aCSF: 10 mM HEPES, 4 mM KCl, 1.5 mM CaCl.sub.2, 0.75 mM MgCl2, 139 mM NaCl, 10 mM D-glucose, adjusted with sucrose to an osmolarity of 325 mOsm, and with NaOH to a pH of 7.4). Images were acquired with an EMCCD camera (Andor Ixon-885) mounted on an Olympus upright microscope (BX51WI) using a 20 water immersion objective (Olympus, LUMPLFL NA 0.4).
[0086] Fluorescent excitation was provided via a 120 W mercury lamp (EXFO x-cite 120PC) coupled to a GFP filter cube (Chroma T495LP). Images were acquired at 59 fps in 22 binning mode using Andor software data-acquisition card (SOLIS) installed on a personal computer, spooled to a high capacity hard drive and stored as uncompressed multi-page tiff file libraries.
[0087] Electrical Recordings from Retinas
[0088] Coupling between the tissue and the electrodes was improved by placing a small piece of polyester membrane filter (5 m pores; Sterlitech) and a ring weight on the retina. The filter was removed before light stimulation to minimize scattering. Retinas were kept at physiological conditions, at a temperature of 34 C., and perfused (2-5 mL/min) with oxygenated (95% O.sub.2, 5% CO.sub.2) chick aCSF solution (5 mM KCl, 25 mM NaHCO.sub.3, 9 mM glucose, 1.2 mM MgSO.sub.4, 1.2 mM HEPES, 0.5 mM glutamine, 2.5 mM CaCl.sub.2). Neuronal signals were amplified (gain 1100 MEA1060-UP; MultiChannel Systems), digitized using a 64-channel analogue to digital converter (MC_Card; MultiChannel Systems), and recorded (MC_Rack; MultiChannel Systems). Direct retinal responses were recorded with 30-m diameter TiN electrode MEAs, using electrical stimuli generated by an external stimulator. In vitro epiretinal stimulation was carried out using a biphasic pulse of 300 s and found a critical threshold for eliciting retinal responses of 0.4-1.4 mC/cm.sup.2, similar to what has been reported in the literature.
[0089] Organic Electrolytic Photocapacitors
[0090] The organic thin film electrolytic capacitor we introduce here is a photodiode which produces electrical double layers upon illumination in water (
[0091] For photocapacitor characterization, we first fabricated 1.51.5 cm metallized (Cr/Au) glass slides with 1 cm.sup.2 square p-n layer (denoted as type I samples). This arrangement was used to establish baseline parameters for photovoltage/photocurrent, spectral response, and stability. The gold electrode was wired to be grounded or floating (
[0092] The photovoltage build-up created in solution was next studied above the photocapacitor, this parameter being defined as the transient voltage, V.sub.t. This is measured with a glass micropipette electrode in solution mounted on a micromanipulator. All measurements were taken with the micropipette tip 10 m above the pigment surface, versus a large Ag/AgCl bath reference electrode, to give a realistic impression of what voltage perturbations cells adhered to the devices will encounter (
[0093] For proper operation in electrophysiological applications, devices must be stable in aqueous environments and compatible with sterilization procedures. We measured samples over several days in PBS solution without noting decrease of recorded photovoltage. Accelerated stress test involving sequential treatment with oxygen plasma, ethanol, incubation in cell culture medium, followed by UV sterilization treatment and repeated ethanol rinsing were performed to validate device stability (
[0094] Photostimulation of Cultured Primary Neurons
[0095] Having established details on the relationships between device structure and photovoltage behaviour, we proceeded to demonstrate stimulation of primary neuronal cultures (
[0096] From Film to Pixels
[0097] While larger uniform films are a simple platform for stimulating neurons, patterned pixels offer several possible advantages including integration with recording electrode arrays and stimulation localization. Decrease in the lateral dimensions of the device is also required for effective retinal implants or other applications requiring electrical stimulation. To design devices for effective stimulation using isolated islands, samples with p-n areas of different sizes, ranging from 200 to 1000 m in diameter, on top of a large, (type II), or finite (type III) gold surface area were fabricated and their V.sub.t was measured as described before (
[0098] Photostimulation of a Blind Retina Model
[0099] The embryonic chick retina is a well-established model for the development of the visual system and the retina in particular. At embryonic day 14 (E14), retinal cells are in an early maturation stage, but the retina is not yet sensitive to light. Opsins mRNA only begins to appear in a small region by then, while photoreceptor electrical activity in response to light is not detected before E17. Thus, at this stage of development, the chick retina serves as a light insensitive retinal model.
[0100] Retinas (E14) were placed on type II or type III device-modified MEAs (
Discussion
[0101] The devices studied are free-standing (electrically-floating structures) and are fabricated via scalable fabrication steps where the substrate remains at room temperature, which allows integration with arbitrary substrate materials. While silicon based photodiodes have so far played a dominant role in the realm of artificial photoelectrical stimulation of neurons, silicon devices have several shortcomings compared with organic pigment layers. First, pigment films have a higher absorbance coefficient, allowing them to efficiently absorb light. At 660 nm, used in this work, the absorbance coefficient of vacuum-evaporated H.sub.2Pc is 310.sup.5 cm.sup.1, while silicon is 2.5810.sup.3 cm.sup.1. This difference allows making thinner photoactive films much less invasive, as the devices can have thicknesses that are much smaller than single cells. Our devices are 500 times thinner than the thinnest state-of-the-art silicon diodes for retinal implants. Moreover, in our design, one has a nanostructured semiconductor surface in direct contact with the electrolytic medium/biological sample, there is no voltage drop on a passivation layer or on conducting interconnects in between. Silicon photocapacitive devices charge metal electrodeshere we have the semiconductor surface itself serving as the primary charge-carrying electrode. Secondary metal electrodes must be employed in the case of silicon since it is not stable in physiological aqueous media. It must be carefully encapsulated, and interconnects passivated using SiO.sub.2/Si.sub.3N.sub.4 layers, for example. The organic p-n layers can make direct contact with the physiological environment due to their durability. Organic crystalline pigments like phthalocyanine and perylene bisimides are famously indestructible in terms of chemical and photochemical stability. Further, the nontoxicity of both phthalocyanines and perylene pigments is well-documented. These materials are used in cosmetics, medical products, and tattoos. They are commercial colorants which belong to the lowest category of hazard and toxicity for consumer approved materials in the EU.
[0102] Achieving temporal control over neural stimulation requires activation with short latency of the response. In the case of retinal stimulation, such short latency responses are attributed to directly activating the retinal ganglion cells (RGCs), when the electrodes are placed on top of the inner limiting membrane (ILM) at the epiretinal side, or to the inner nuclear layer (INL), when the electrodes are positioned subretinally, next to the degenerated photoreceptors. Direct activation of RGCs means that each stimulation pulse produces short latency synchronized action potentials (AP) in several somas and axons of RGCs that are located at the vicinity of stimulating electrode. On the contrary, stimulation of inner retinal neurons results in the generation of bursts of unsynchronized spikes in the RGCs with much longer latency, due to synapse transmission. Therefore, a major challenge in neuronal activation, in particular with photosensitive nanostructures, is to understand and to control the mechanism by which the activation is achieved, aiming for a sufficient charge injection for obtaining direct electrical activation similar to that of the best-optimized silicon-based electronics. Moreover, such electrical stimulation should be capacitive, which is considered safe and can be used for extended duration, unlike faradaic stimulation and thermal activation that are not considered optimal and should be avoided.
[0103] The retinal setup involves laying the RGC on top of the organic pigment, as in the case of epiretinal stimulation, while illuminating from the direction of the photoreceptors. This light trajectory is opposite to what is normal physiologically, but it does not contradict with the focus of this work, showing that the photoelectric transduction of our device is sufficient to stimulate neural tissue in a direct electrical manner at safe light intensities. In terms of neuronal stimulation benchmark parameters, our ultrathin organic device reaches parity with the state-of-the-art silicon diode-based technologies. This presents the ability to evoke action potentials in retinas using the same light intensity range as triple-tandem silicon retinal stimulation diodes. The range of pulsed light intensities and durations we have used has been deemed two orders of magnitude below the safe limit for ocular stimulation. Moreover, 660 nm is within the biological tissue transparency window, which can enable a host of other applications in peripheral nerve stimulation.
[0104] To conclude, we demonstrated a new and advantageous concept to photostimulate neurons. Primary neurons were cultured on our photocapacitor devices for three weeks, demonstrating viability of both the devices and the cells. The latter could readily be photostimulated using short impulses of light. We next integrated photocapacitors onto commercial MEAs, enabling simultaneous photoexcitation and recording. Using this platform, we demonstrated effective direct photostimulation of light-insensitive embryonic chicken retinas. The MEA allows us to make an in situ control of conventional electrical stimulation, thereby we verify that the photocapacitor arrays and the electrical stimulation have the exact same retinal response. We experimentally discount the presence of photothermal heating effects. The culmination of this work are stand-alone photocapacitors with organic pixels of 100 m in diameter to locally and reproducibly evoke action potentials. Future research of this device concept should involve optimizing materials to afford higher responsivity and photovoltage, allowing smaller pixels and lower light intensities. Different nano- and microstructuring of the organic material must be explored to yield optimal coupling with cells. The technology is a new platform that can interact with living cells via a true capacitive coupling mechanism, thus enabling safe and versatile next-generation implant technologies, and already at the level demonstrated here is suitable for various in vivo applications in peripheral or central nervous system stimulation, for example in the context of traumatic injury. Success in these efforts requires deployment of the devices on implantable and/or bioresorbable substrates, and evaluation of their stability and performance in vivo.